Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Tests a phone app for quality of life in people with endometriosis

Tests an app-based program in people with suspected or confirmed endometriosis.

Plain-language title generated from the registry record
Registry title: The Effect of an App-based Intervention on Quality of Life in Patients With Endometriosis.

Key facts

Where
Bern, SwitzerlandSee the site

Where in Switzerland

  • Department of Gynecology and Obstetrics, Women's University Hospital, Inselspital Bern, University of BernBern, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Insel Gruppe AG, University Hospital Bern
Trial code
NCT06821217
Record updated
14 February 2025
Original description
The goal of this clinical trial is to learn if an App-based intervention affects the quality of life in patients with suspected or confirmed endometriosis. The main questions it aims to answer are:Read full original descriptionShow less

A Mobile Application as Supportive Treatment of Endometriosis: the Effect on Quality of Life and Endometriosis-associated Pain. A Randomized Controlled Trial.

The goal of this clinical trial is to learn if an App-based intervention affects the quality of life in patients with suspected or confirmed endometriosis. The main questions it aims to answer are:

* Does the App-based intervention improve the quality of life? * Does it lead to pain relief? Researchers will compare participants using the App to a control group to see if the App works to improve quality of life and endometriosis-related symptoms.

Participants will:

* Use an App-based intervention or be in the control group (no App-use) for 6 months * Visit or have a telephone consultation after 3 and 6 months * Complete a questionnaire to assess the quality of life at inclusion, after 1, 3 and 6 months

Inclusion: Informed Consent as documented by signature; Age 18 or older; Premenopausal status (menopause is defined as amenorrhea lasting one year or longer); Endometriosis, confirmed by surgery or clinically suspected; Possession of a smartphone.

Exclusion: Planned endometriosis surgery or planned hormonal therapy in the study period; Surgery and/or new hormonal therapy in the last three months; Malignant diseases; Pregnancy; Breastfeeding; Active desire for pregnancy in the study period; Fertility treatment; Simultaneous participation in other intervention studies.

ClinicalTrials.gov NCT06821217